hollensteinlab.bsky.social
@hollensteinlab.bsky.social
Our group focuses on generating modified aptamers and developing chemoenzymatic methods for the synthesis of chemically modified, therapeutic oligonucleotides
Interested by 3D modified aptamers? Then check out our recent article by undergraduate student Charlotte and postdoc Usman.
nature.com/articles/s4200…
@ipdbsc.bsky.soci
al @pasteur.fr @cnrs.fr
https://nature.com/articles/s4200…
September 16, 2025 at 5:42 AM
Very happy to share our preprint @ChemRxiv on the selection of Ru-modified aptamers. Long in the making. Congrats to all authors. Great collaboration with @gassergroup.bsky.social
@pasteur.fr @ipdbsc.bsky.social @cnrs.fr
10.26434/chemrxiv-2025-dd90p
July 25, 2025 at 8:07 AM
Very much looking forward presenting our research at #biotrans2025 in Basel. Thanks again for the kind invitation!
June 30, 2025 at 12:10 PM
Very happy to share out new pre-print on the enzymatic GalNAc-labelling of oligonucleotides. Big congrats to undergraduate student Elisa and graduate student @pierrenicolasbizat.bsky.social!
chemrxiv.org/engage/chemr...
@pasteur.fr @ipdbsc.bsky.social @cnrs.fr
Towards the enzymatic labelling of oligonucleotides with triantennary N-acetyl galactosamine
The inclusion of chemical modifications into oligonucleotides stabilizes their backbones against nuclease mediated degradation and improves their biological activity. Even though cellular, tissue, and...
chemrxiv.org
May 27, 2025 at 1:49 PM
Reposted
Et si notre organisme devenait une usine à médicaments, capable de produire lui-même des anticorps pour lutter contre les virus ? C’est le défi ambitieux que relève ReNAissance !

🤝 @cnrs-bretagneloire.bsky.social @inserm.fr
ReNAissance : révolutionner les traitements antiviraux grâce à l’ARN messager
Et si notre organisme devenait une usine à médicaments, capable de produire lui-même des anticorps pour lutter contre les virus ?
buff.ly
March 26, 2025 at 2:00 PM
March 27, 2025 at 3:53 PM
very happy to work with my colleague Bruno Pitard on therapeutic RNAs. We thank @inserm.fr for selecting our project and for the very generous funding!
@pasteur.fr @ipdbsc.bsky.social @hollensteinlab.bsky.social
inserm.fr Inserm @inserm.fr · Mar 10
L’Inserm présente aujourd’hui les quinze projets sélectionnés dans le cadre du programme Impact Santé.

Lire le communiqué : presse.inserm.fr/impact-sante...
March 12, 2025 at 9:03 AM
Reposted
L’Inserm présente aujourd’hui les quinze projets sélectionnés dans le cadre du programme Impact Santé.

Lire le communiqué : presse.inserm.fr/impact-sante...
March 10, 2025 at 2:57 PM
Thrilled to share our article published
@chemsocrev.bsky.social on sugar modified nucleic acids. Congrats to Debashis! Great collaboration with Laurence Mulard. @pasteur.fr @ipdbsc.bsky.social @chem4life.bsky.social @cnrs.fr
pubs.rsc.org/en/content/a...
Natural, modified and conjugated carbohydrates in nucleic acids
Storage of genetic information in DNA occurs through a unique ordering of canonical base pairs. However, this would not be possible in the absence of the sugar–phosphate backbone which is essential fo...
pubs.rsc.org
February 12, 2025 at 10:40 AM
Reposted
Fantastic opportunity!
February 11, 2025 at 3:57 PM
Reposted
Probing three-dimensional cyclooctatetraene as nucleobase modification in aptamer selection

Authors: Greta Charlotte Dahm, Usman Akhtar, Alix Bouvier-Müller, Laura Lim, Fabienne Levi-Acobas, Pierre Nicolas Bizat, Germain Niogret, Julian Tanner, ...
DOI: 10.26434/chemrxiv-2025-cglxw
February 3, 2025 at 11:00 AM
Very happy to share our new preprint on the selection of COT-modified aptamers. Great work by undergraduate student Charlotte. Congrats to all!
chemrxiv.org/engage/chemr...
Stay tuned for the published version.
@pasteur.fr @chem4life.bsky.social @hollensteinlab.bsky.social @chemrxiv.bsky.social
Probing three-dimensional cyclooctatetraene as nucleobase modification in aptamer selection
Decoration of aptamers with chemical modifications at the level of nucleobases grants access to alternative binding modes which often result in improved binding properties. Most functional groups invo...
chemrxiv.org
February 3, 2025 at 11:50 AM
Thrilled to share our review on biocatalytic methods for the synthesis of (modified) oligonucleotides. Congratulations to Pierre Nicolas and Nazarii! Thank you to Dr. Juan Jin and @rubenragg.bsky.social for their invitation!https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.202400987
January 24, 2025 at 2:32 PM
Reposted
It was nice to be in the jury of Joseph Boissieras at the Institut Curie in Orsay yesterday and to meet, among others, with @hollensteinlab.bsky.social. Thanks to @granzhan.bsky.social for the invitation.
Congratulations to the new doctor. All the very best for your future Joseph.
December 10, 2024 at 1:32 PM